Education
About Us
Working with TipRanks
Follow Us
B Lafrenière Pierre Insider Profile
4 Followers
B Lafrenière Pierre, Director at LSL Pharma Group Inc, holds 25.00K shares in LSL Pharma Group Inc (Ticker: TSE:LSL). Most recently, B Lafrenière Pierre Bought C$25,000 shares of LSL Pharma Group Inc on May 31, 2025 for an estimated value of 9.47K.
B Lafrenière Pierre has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of B Lafrenière Pierre's holdings
Insider Roles
Director
Roles that B Lafrenière Pierre holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by B Lafrenière Pierre
B Lafrenière Pierre's Trading History
List of latest transactions for each holding click on a transaction to see B Lafrenière Pierre's performance on stock
You May Also Like
B Lafrenière Pierre insider profile FAQ
What is the percentage of profitable transactions made by B Lafrenière Pierre?
The percentage of profitable transactions made by B Lafrenière Pierre is ―.
What is the average return per transaction made by B Lafrenière Pierre?
The average return per transaction made by B Lafrenière Pierre is ―.
What stocks does B Lafrenière Pierre hold?
B Lafrenière Pierre holds: TSE:LSL stocks.
What was B Lafrenière Pierre’s latest transaction?
B Lafrenière Pierre latest transaction was an Informative Buy of C$9.47K.
What was B Lafrenière Pierre's most profitable transaction?
B Lafrenière Pierre’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is B Lafrenière Pierre's role in LSL Pharma Group Inc?
B Lafrenière Pierre's role in LSL Pharma Group Inc is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.